Title |
Emergency Neurological Life Support: Resuscitation Following Cardiac Arrest
|
---|---|
Published in |
Neurocritical Care, August 2012
|
DOI | 10.1007/s12028-012-9750-9 |
Pubmed ID | |
Authors |
Jon C. Rittenberger, Kees H. Polderman, Wade S. Smith, Scott D. Weingart |
Abstract |
Cardiac arrest is the most common cause of death in North America. Neurocritical care interventions, including therapeutic hypothermia (TH), have significantly improved neurological outcomes in patients successfully resuscitated from cardiac arrest. Therefore, resuscitation following cardiac arrest was chosen as an Emergency Neurological Life Support protocol. Patients remaining comatose following resuscitation from cardiac arrest and who are not bleeding are potential candidates for TH. This protocol will review induction, maintenance, and re-warming phases of TH, along with management of TH side effects. Aggressive shivering suppression is necessary with this treatment to ensure the maintenance of a target temperature. Ancillary testing, including electrocardiography, computed tomography imaging of the brain, continuous electroencephalography, monitoring, and correction of electrolyte, blood gas, and hematocrit changes are also necessary to optimize outcomes. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 2 | 2% |
United States | 2 | 2% |
United Kingdom | 1 | <1% |
Canada | 1 | <1% |
South Africa | 1 | <1% |
Korea, Republic of | 1 | <1% |
Denmark | 1 | <1% |
Spain | 1 | <1% |
Russia | 1 | <1% |
Other | 0 | 0% |
Unknown | 102 | 90% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 23 | 20% |
Researcher | 18 | 16% |
Student > Postgraduate | 13 | 12% |
Professor > Associate Professor | 11 | 10% |
Student > Doctoral Student | 6 | 5% |
Other | 27 | 24% |
Unknown | 15 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 83 | 73% |
Neuroscience | 3 | 3% |
Nursing and Health Professions | 2 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | <1% |
Agricultural and Biological Sciences | 1 | <1% |
Other | 5 | 4% |
Unknown | 18 | 16% |